Free Trial

Howard Hughes (HHH) Competitors

Howard Hughes logo
$70.57 -0.55 (-0.77%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$70.75 +0.18 (+0.26%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HHH vs. TSHA, ZG, WPC, GLPI, AMH, HLI, REG, DOC, JEF, and HST

Should you be buying Howard Hughes stock or one of its competitors? The main competitors of Howard Hughes include Taysha Gene Therapies (TSHA), Zillow Group (ZG), W.P. Carey (WPC), Gaming and Leisure Properties (GLPI), American Homes 4 Rent (AMH), Houlihan Lokey (HLI), Regency Centers (REG), Healthpeak Properties (DOC), Jefferies Financial Group (JEF), and Host Hotels & Resorts (HST).

Howard Hughes vs. Its Competitors

Taysha Gene Therapies (NASDAQ:TSHA) and Howard Hughes (NYSE:HHH) are related companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

77.7% of Taysha Gene Therapies shares are held by institutional investors. Comparatively, 93.8% of Howard Hughes shares are held by institutional investors. 3.8% of Taysha Gene Therapies shares are held by company insiders. Comparatively, 33.0% of Howard Hughes shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Taysha Gene Therapies has a beta of 0.97, meaning that its share price is 3% less volatile than the S&P 500. Comparatively, Howard Hughes has a beta of 1.21, meaning that its share price is 21% more volatile than the S&P 500.

Howard Hughes has a net margin of 14.27% compared to Taysha Gene Therapies' net margin of -1,201.08%. Howard Hughes' return on equity of 10.21% beat Taysha Gene Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Taysha Gene Therapies-1,201.08% -104.93% -50.09%
Howard Hughes 14.27%10.21%3.08%

Howard Hughes has higher revenue and earnings than Taysha Gene Therapies. Taysha Gene Therapies is trading at a lower price-to-earnings ratio than Howard Hughes, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Taysha Gene Therapies$7.22M78.45-$89.30M-$0.34-7.76
Howard Hughes$1.75B2.03$200.55M$5.2113.55

Taysha Gene Therapies currently has a consensus price target of $8.17, indicating a potential upside of 209.34%. Howard Hughes has a consensus price target of $80.33, indicating a potential upside of 13.83%. Given Taysha Gene Therapies' stronger consensus rating and higher probable upside, equities analysts plainly believe Taysha Gene Therapies is more favorable than Howard Hughes.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Taysha Gene Therapies
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
Howard Hughes
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Howard Hughes had 1 more articles in the media than Taysha Gene Therapies. MarketBeat recorded 6 mentions for Howard Hughes and 5 mentions for Taysha Gene Therapies. Taysha Gene Therapies' average media sentiment score of 0.70 beat Howard Hughes' score of 0.60 indicating that Taysha Gene Therapies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Taysha Gene Therapies
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Howard Hughes
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Howard Hughes beats Taysha Gene Therapies on 11 of the 16 factors compared between the two stocks.

Get Howard Hughes News Delivered to You Automatically

Sign up to receive the latest news and ratings for HHH and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HHH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HHH vs. The Competition

MetricHoward HughesREAL ESTATE DEV IndustryFinance SectorNYSE Exchange
Market Cap$3.55B$2.49B$12.08B$20.62B
Dividend YieldN/A2.89%5.54%3.72%
P/E Ratio13.558.7519.2027.81
Price / Sales2.033.0225.7140.78
Price / Cash7.2825.2621.4522.32
Price / Book1.250.962.284.57
Net Income$200.55M-$100.65M$992.82M$989.30M
7 Day Performance1.71%0.52%-0.20%0.20%
1 Month Performance1.94%2.25%3.93%5.53%
1 Year Performance-1.45%-1.17%539.45%10.30%

Howard Hughes Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HHH
Howard Hughes
2.569 of 5 stars
$70.57
-0.8%
$80.33
+13.8%
-1.5%$3.55B$1.75B13.55608News Coverage
TSHA
Taysha Gene Therapies
4.0581 of 5 stars
$2.34
-4.5%
$8.20
+250.4%
+11.4%$525.92M$8.33M-6.88180News Coverage
Analyst Forecast
ZG
Zillow Group
4.3644 of 5 stars
$70.43
+0.2%
$81.80
+16.1%
+54.0%$16.98B$2.24B-207.156,856Analyst Forecast
WPC
W.P. Carey
4.6104 of 5 stars
$62.60
-1.0%
$100.60
+60.7%
+7.7%$13.85B$1.60B32.27190Positive News
GLPI
Gaming and Leisure Properties
4.6472 of 5 stars
$47.59
-1.3%
$54.17
+13.8%
-0.7%$13.25B$1.55B16.9420Positive News
AMH
American Homes 4 Rent
4.7013 of 5 stars
$35.42
-0.5%
$40.90
+15.5%
-0.7%$13.18B$1.73B32.801,730Positive News
HLI
Houlihan Lokey
4.5047 of 5 stars
$185.15
-0.2%
$192.20
+3.8%
+33.9%$12.95B$2.39B31.811,100News Coverage
Positive News
Analyst Forecast
REG
Regency Centers
3.8207 of 5 stars
$69.92
-1.2%
$78.00
+11.6%
+8.3%$12.85B$1.45B32.98440News Coverage
Positive News
DOC
Healthpeak Properties
4.9752 of 5 stars
$17.97
-1.4%
$23.27
+29.5%
-10.2%$12.66B$2.70B44.93200News Coverage
Positive News
Dividend Announcement
JEF
Jefferies Financial Group
4.5498 of 5 stars
$55.60
-2.4%
$66.00
+18.7%
+1.6%$11.74B$7.03B20.987,822Trending News
HST
Host Hotels & Resorts
3.3659 of 5 stars
$16.01
-1.2%
$17.96
+12.2%
-9.1%$11.25B$5.68B16.68160News Coverage
Analyst Revision

Related Companies and Tools


This page (NYSE:HHH) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners